SIBN
SI-BONE, Inc.Company Information
- Company Name
- SI-BONE, Inc.
- CIK
- CIK0001459839
- Category
- Large accelerated filer
- Ticker: Exchange
- SIBN: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- SIBN
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2026-09-01
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 505,551
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 47,053,830
- Shares outstanding
- 44,477,113
- Ownership
- 105.79%
Earnings Market Reaction
- Filing date
- 2026-08-04
- Price on filing date
- —
- 1-month reaction
- 4.18%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 33 | 34 | 42 | 26 | 34 | 41 | 35 | 30 | 26 | 32 | 33 | 53 | ||||||
| Debt Securities Available For Sale Excluding Accrued Interest Current | 113 | 111 | 106 | 119 | 111 | 103 | 115 | 121 | 126 | 126 | 133 | 113 | ||||||
| Accounts Receivable Net Current | 31 | 31 | 30 | 27 | 24 | 27 | 27 | 25 | 25 | 22 | 22 | 20 | ||||||
| Inventory Net | 38 | 36 | 34 | 36 | 34 | 30 | 27 | 26 | 23 | 21 | 20 | 22 | ||||||
| Prepaid Expense And Other Assets Current | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 3 | 2 | ||||||
| Assets Current | 220 | 215 | 216 | 211 | 207 | 204 | 208 | 204 | 202 | 204 | 211 | 211 | ||||||
| Property Plant And Equipment Net | 22 | 20 | 21 | 22 | 22 | 21 | 20 | 21 | 19 | 17 | 16 | 16 | ||||||
| Operating Lease Right Of Use Asset | 7 | 7 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 249 | 243 | 239 | 234 | 231 | 227 | 230 | 227 | 224 | 224 | 230 | 231 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 9 | 7 | 5 | 8 | 7 | 8 | 6 | 7 | 7 | 8 | 5 | 4 | ||||||
| Accrued Liabilities Current | 15 | 14 | 20 | 18 | 16 | 15 | 19 | 16 | 13 | 12 | 17 | 14 | ||||||
| Operating Lease Liability Current | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Liabilities Current | 24 | 21 | 25 | 26 | 25 | 24 | 27 | 25 | 22 | 21 | 23 | 19 | ||||||
| Long Term Debt Noncurrent | 36 | 36 | 36 | 36 | 36 | 35 | 35 | 36 | 36 | 36 | 36 | 36 | ||||||
| Operating Lease Liability Noncurrent | 7 | 7 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | ||||||
| Other Liabilities Noncurrent | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 66 | 64 | 61 | 62 | 61 | 60 | 63 | 62 | 59 | 58 | 61 | 57 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 641 | 633 | 627 | 620 | 614 | 605 | 598 | 591 | 585 | 577 | 569 | 563 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | ||||||
| Retained Earnings Accumulated Deficit | -459 | -455 | -450 | -449 | -444 | -438 | -431 | -427 | -420 | -411 | -400 | -389 | ||||||
| Stockholders Equity | 182 | 179 | 178 | 172 | 170 | 167 | 167 | 165 | 165 | 166 | 169 | 174 | ||||||
| Liabilities And Stockholders Equity | 249 | 243 | 239 | 234 | 231 | 227 | 230 | 227 | 224 | 224 | 230 | 231 | ||||||
| Allowance For Doubtful Accounts Receivable Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | ||||||
| Common Stock Shares Issued | 45 | 44 | 44 | 43 | 43 | 42 | 42 | 42 | 42 | 41 | 41 | 40 | ||||||
| Shares Outstanding | 45 | 44 | 44 | 43 | 43 | 42 | 42 | 42 | 42 | 41 | 41 | 40 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialSI-BONE, Inc. (SIBN) — SEC Financial Statements & Analysis
SI-BONE, Inc. (SIBN) is a surgical & medical instruments & apparatus company, incorporated in DE. SI-BONE, Inc. trades on Nasdaq as: SIBN. SI-BONE, Inc. (SIBN)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-04. Based on that filing, SI-BONE, Inc. carries a market cap of $725.87M, a P/E ratio of -49.61x, a P/B ratio of 3.98x, a P/S ratio of 3.40x, an enterprise value of $728.37M, and an EV/EBITDA multiple of -64.31x. On profitability, it posts a gross margin of 79.53%, an operating margin of -8.31%, a net margin of -6.85%, a Return on Equity (ROE) of -8.30%, a Return on Assets (ROA) of -6.10%, and a Return on Invested Capital (ROIC) of -9.74%. Per share, it reports EPS of $-0.33, diluted EPS of $-0.33, free cash flow per share of $-0.10, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 15.30% year-over-year, net income growth of -38.43% year-over-year, and EPS growth of -40.77% year-over-year. On the balance sheet, it maintains a current ratio of 9.15x, a quick ratio of 7.37x, working capital of $195.87M, a debt-to-equity ratio of 0.36x, a debt ratio of 0.27, an interest coverage ratio of -7.13x, free cash flow of $-4.39M (TTM), and net debt of $2.50M. Figures sourced from SEC EDGAR.
- Market Cap
- $725.87M
- P/E TTM
- -49.61x
- EPS TTM
- $-0.33
- P/B TTM
- 3.98x
- ROE TTM
- -8.30%
- ROA TTM
- -6.10%
- Debt To Equity
- 0.36x
- Free Cash Flow TTM
- $-4.39M
- Net Revenue TTM Growth 1Y
- 15.30%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is SI-BONE, Inc. in?
SI-BONE, Inc. (SIBN) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does SIBN trade on?
SI-BONE, Inc. (SIBN) trades on the Nasdaq.
Where is SI-BONE, Inc. incorporated?
SI-BONE, Inc. is incorporated in DE.
When was SI-BONE, Inc. (SIBN)'s most recent SEC filing?
SI-BONE, Inc. (SIBN)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-04.
What is SIBN's market cap?
SI-BONE, Inc. (SIBN) has a market capitalization of $725.87M as of 2026-06-30.
What is SIBN's EPS (earnings per share)?
SI-BONE, Inc. (SIBN)'s trailing twelve month EPS is $-0.33 as of 2026-06-30.
What is SIBN's ROE (return on equity)?
SI-BONE, Inc. (SIBN)'s trailing twelve month Return on Equity (ROE) is -8.30% as of 2026-06-30.
What is SIBN's ROA (return on assets)?
SI-BONE, Inc. (SIBN)'s trailing twelve month Return on Assets (ROA) is -6.10% as of 2026-06-30.
What is SIBN's ROIC (return on invested capital)?
SI-BONE, Inc. (SIBN)'s trailing twelve month Return on Invested Capital (ROIC) is -9.74% as of 2026-06-30.
What is SIBN's EV/EBITDA?
SI-BONE, Inc. (SIBN)'s trailing twelve month EV/EBITDA is -64.31x as of 2026-06-30.